These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913 [TBL] [Abstract][Full Text] [Related]
5. APOE, vascular pathology, and the AD brain. Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics. Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827 [TBL] [Abstract][Full Text] [Related]
7. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease. Choi SH; Kim SY; Na HR; Kim BK; Yang DW; Kwon JC; Park MY Dement Geriatr Cogn Disord; 2008; 25(5):445-50. PubMed ID: 18401173 [TBL] [Abstract][Full Text] [Related]
8. An observational study on the influence of the APOE-epsilon4 allele on the correlation between 'free' copper toxicosis and EEG activity in Alzheimer disease. Zappasodi F; Salustri C; Babiloni C; Cassetta E; Del Percio C; Ercolani M; Rossini PM; Squitti R Brain Res; 2008 Jun; 1215():183-9. PubMed ID: 18486114 [TBL] [Abstract][Full Text] [Related]
9. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression. Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324 [TBL] [Abstract][Full Text] [Related]
10. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169 [TBL] [Abstract][Full Text] [Related]
11. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele. Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606 [TBL] [Abstract][Full Text] [Related]
12. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Lind J; Persson J; Ingvar M; Larsson A; Cruts M; Van Broeckhoven C; Adolfsson R; Bäckman L; Nilsson LG; Petersson KM; Nyberg L Brain; 2006 May; 129(Pt 5):1240-8. PubMed ID: 16537568 [TBL] [Abstract][Full Text] [Related]
13. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls. Kramer G; van der Flier WM; de Langen C; Blankenstein MA; Scheltens P; Stam CJ Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805 [TBL] [Abstract][Full Text] [Related]
14. The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology. Ramakers IH; Visser PJ; Aalten P; Bekers O; Sleegers K; van Broeckhoven CL; Jolles J; Verhey FR Dement Geriatr Cogn Disord; 2008; 26(2):101-8. PubMed ID: 18617739 [TBL] [Abstract][Full Text] [Related]
15. [Study of relationship between ApoE epsilon4 allele and hippocampal atrophy in Alzheimer disease]. Li J; Kuang WH; Li J; Wang X; Huang MS; Wu DP Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):50-2. PubMed ID: 15702779 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia. Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951 [TBL] [Abstract][Full Text] [Related]
18. Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer disease. Blesa R; Aguilar M; Casanova JP; Boada M; Martínez S; Alom J; de la Hoz CH; Sancho J; Fernández O; Gil-Neciga E; Massó JF Alzheimer Dis Assoc Disord; 2006; 20(4):248-54. PubMed ID: 17132969 [TBL] [Abstract][Full Text] [Related]
19. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402 [TBL] [Abstract][Full Text] [Related]
20. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]